EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Whole genome sequencing for copy number variant detection to improve diagnosis and management of rare diseases

Pamela Bowman iD, Hannah Grimes, Anthony R Dallosso iD, Ian Berry, Stephen Mullin, Julia Rankin, Karen J Low

Developmental Medicine & Child Neurology · 2025-01 · 67 (1) · 126-131

DOI: 10.1111/dmcn.15985 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Developmental Medicine & Child Neurology, online erschienen am 05.06.2024. Verfasst von Pamela Bowman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Genetics, Royal Devon University NHS Foundation Trust, Exeter, UK. Hauptthemen laut MEDLINE: DNA Copy Number Variations, Rare Diseases, Whole Genome Sequencing. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

First‐line genetic investigations for rare neurological and developmental conditions have limitations in their ability to detect and characterize copy number variants (CNVs). Whole genome sequencing (WGS) offers potential advantages over other methods of CNV analysis. We aimed to demonstrate the utility of CNV detection using WGS through description of three clinical cases. WGS analysis was undertaken in three patients presenting to a national rare disease service, in whom a genetic aetiology remained uncertain after gene panel testing or microarray based comparative genomic hybridization (array CGH). In all three cases, WGS identified CNVs and confirmed zygosity and pathogenicity, resulting in genetic diagnoses of PRKN ‐related Parkinson disease, TAOK1 ‐related neurodevelopmental disorder, and AP1G1 ‐related Usmani‐Riazuddin syndrome. This case series demonstrates the value of WGS analysis in identifying or better characterizing CNVs that were missed or deemed of uncertain significance using conventional methods of testing. Importantly, our approach facilitated accurate genetic diagnosis and counselling for the families involved.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA Copy Number VariationsRare DiseasesWhole Genome SequencingChild, PreschoolHumansNeurodevelopmental DisordersParkinson DiseaseAdultUbiquitin-Protein Ligases

Substanzen

parkin proteinUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Department of Clinical Genetics, Royal Devon University NHS Foundation Trust, Exeter, UK.
  • University of Exeter, Exeter, UK.
  • Somerset NHS Foundation Trust, Taunton, Somerset, UK.
  • South West Genomic Laboratory Hub, North Bristol NHS Trust, Bristol, UK.
  • Department of Neurology, University Hospitals Plymouth NHS Trust, Plymouth, UK.
  • Department of Clinical Genetics, UHBW NHS Trust, Bristol, UK.

ORCID-Profile: Pamela Bowman, Anthony R Dallosso

Förderung

  • National Institute for Health and Care Research

Zitieren

APA

Bowman, P., Grimes, H., Dallosso, A. R., Berry, I., Mullin, S., Rankin, J., & Low, K. J. (2025). Whole genome sequencing for copy number variant detection to improve diagnosis and management of rare diseases. Developmental Medicine & Child Neurology, 67(1), 126-131. https://doi.org/10.1111/dmcn.15985

Vancouver

Bowman P, Grimes H, Dallosso AR, Berry I, Mullin S, Rankin J, et al. Whole genome sequencing for copy number variant detection to improve diagnosis and management of rare diseases. Developmental Medicine & Child Neurology. 2025;67(1):126-131. doi:10.1111/dmcn.15985

BibTeX
@article{Bowman2025,
  author = {Bowman, Pamela and Grimes, Hannah and Dallosso, Anthony R and Berry, Ian and Mullin, Stephen and Rankin, Julia and Low, Karen J},
  title = {Whole genome sequencing for copy number variant detection to improve diagnosis and management of rare diseases},
  journal = {Developmental Medicine & Child Neurology},
  year = {2025},
  volume = {67},
  number = {1},
  pages = {126--131},
  doi = {10.1111/dmcn.15985}
}
Kostenlos starten →